Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Neurobiol Aging. 2017 Jan 3;52:81–89. doi: 10.1016/j.neurobiolaging.2016.12.022

Figure 3.

Figure 3

APOE effect modification was observed for COMT + BDNF additive effect on EF performance. APOE ε4+ carriers had poorer EF performance with increasing allelic risk in the COMT + BDNF risk panel at age 75 years and borderline 9-year decline. In contrast, the APOE ε4- group was protected from the deleterious effect on EF performance and decline with increasing allelic risk in the COMT + BDNF risk panel.